DutyPills.com

Potassium-sparing diuretic / aldosterone antagonist

Spironolactone with liver impairment: dosing and safety

The liver is the main site of metabolism for many medications including Spironolactone (Spironolactone). Liver impairment slows clearance and can raise plasma levels of Spironolactone above the intended range, amplifying side effects. People with chronic liver disease, recent hepatitis or significantly raised liver enzymes need a tailored approach to Spironolactone at 25mg, 50mg, 100mg.

Why liver function matters

Spironolactone undergoes hepatic metabolism through CYP enzymes for many medications. Reduced hepatic function slows this metabolism, prolongs the half-life and raises plasma concentrations. Spironolactone competitively blocks the mineralocorticoid (aldosterone) receptor in the distal tubule of the kidney, reducing sodium reabsorption and potassium excretion. The prescribing information typically classifies severity by Child-Pugh score (A mild, B moderate, C severe) and gives dose adjustments accordingly.

Practical guidance

According to the prescribing information for Spironolactone, baseline liver function tests are recommended before starting Spironolactone in any patient with risk factors and periodically during treatment in chronic liver disease. Severe impairment (Child-Pugh C) often contraindicates Spironolactone or requires substantial dose reduction; mild impairment usually permits standard 25mg, 50mg, 100mg with closer monitoring.

Frequently asked questions

Is Spironolactone safe with liver problems?

Mild liver impairment typically allows Spironolactone at standard or slightly reduced 25mg, 50mg, 100mg with monitoring. Moderate-to-severe impairment often requires substantial dose reduction. Severe (Child-Pugh C) impairment may contraindicate Spironolactone entirely.

Will Spironolactone damage my liver?

Most Potassium-sparing diuretic / aldosterone antagonist medications at standard 25mg, 50mg, 100mg doses do not harm a healthy liver. A small subset can produce drug-induced liver injury in susceptible patients, usually detected by routine ALT/AST monitoring. The prescribing information for Spironolactone lists the documented risk.

Products containing Spironolactone

More on Spironolactone

The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.